Advertisement
Advertisement
AXGN
Axogen, Inc. Common Stock
48.75
USDSponsored
-2.60
-5.06%
Nov 05, 15:59 UTC -5
Closed
After-Market
48.85
+0.10
+0.21%
Axogen, Inc. Common Stock (AXGN) Earnings
AXGN Earnings Reports
Positive Surprise Ratio
AXGN beat 32 of 44 last estimates.
73%
Next Report
Date of Next Report
Feb 22, 2027
Estimate for Q4 26 (Revenue/ EPS)
$83.41M
/$0.14
Implied change from Q3 26 (Revenue/ EPS)
+9.99%
/-33.33%
Implied change from Q4 25 (Revenue/ EPS)
+39.24%
/+100.00%
Axogen, Inc. Common Stock earnings per share and revenue
On Oct 28, 2026, AXGN reported earnings of 0.21 USD per share (EPS) for Q3 26, beating the estimate of 0.14 USD, resulting in a 49.47% surprise. Revenue reached 75.83 million, compared to an expected 74.66 million, with a 1.57% difference. The market reacted with a +31.47% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.14 USD, with revenue projected to reach 83.41 million USD, implying an decrease of -33.33% EPS, and increase of 9.99% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
FAQ
What were Axogen, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Axogen, Inc. Common Stock reported EPS of $0.21, beating estimates by 49.47%, and revenue of $75.83M, 1.57% above expectations.
How did the market react to Axogen, Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 31.47%, changed from $37.46 before the earnings release to $49.25 the day after.
When is Axogen, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 22, 2027.
What are the forecasts for Axogen, Inc. Common Stock's next earnings report?
Based on --
analysts, Axogen, Inc. Common Stock is expected to report EPS of $0.14 and revenue of $83.41M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.